118th Congress Health
H.R. 3093: Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2023
Introduced
- Introduced (completed)
- Passed House (not reached)
- Passed Senate (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2023
This bill requires companies that receive federal funding for research (or a license of the rights to a patent or regulatory test data) for a biomedical product or service to agree to set reasonable prices for the resulting biomedical product or service.
The Department of Health and Human Services (HHS) must determine a reasonable price based on a formula that ensures the U.S. price for the product or service is not more than the median price for the product or service in Canada and six other reference countries with, based on specified criteria, large economies and high incomes.
Read the full summary
Companies entering these agreements also must report to HHS certain financial information related to the biomedical product or service involved.
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Cosponsors
- Steve Cohen D-TNOriginal
- Rosa DeLauro D-CTOriginal
- Lloyd Doggett D-TXOriginal
- Raúl Grijalva D-AZOriginal
- Jesús García D-ILOriginal
- Pramila Jayapal D-WAOriginal
- Marcy Kaptur D-OHOriginal
- Ro Khanna D-CAOriginal
- Eleanor Norton D-DCOriginal
- Chellie Pingree D-MEOriginal
- Mark Pocan D-WIOriginal
- Janice Schakowsky D-ILOriginal
- Melanie Stansbury D-NMOriginal
- Jill Tokuda D-HIOriginal
- Gregorio Casar D-TX
- Mark Takano D-CA
- Seth Magaziner D-RI
- Rashida Tlaib D-MI
Who scored on this bill
No member has earned points from it yet.
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Valerie Hoyle
History
- Introduced in the House by Valerie Hoyle.
Show the full action history (3 actions)
- Referred to the Subcommittee on Health.
- Introduced in House
- Referred to the House Committee on Energy and Commerce.